Showing 18745–18756 of 21871 results

SITAGLU MET 50/500MG TAB(HILTON)

536.62
Sitagliptin, a DPP-4 inhibitor, enhances the activities of GLP-1 and GIP, which leads to improved glycemic control in patients with

SITAGLU MET 50/850MG TAB(HILTON)

255.00
By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a

SITAPHAGE 50/1000MG

445.00
<h6>By increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a